Skip to content

HM Pharma

Active Private limited companyfounded 2021active for 5 yearsKoolskampstraat 69, 8740 PittemKBO/BCE: BE 0765.423.931

Annual accounts 2026

abbreviated format, filed on 28-09-2026, 33 days before the deadline
€192,466
▼ 2.0%
€90,561
▼ 11.4%
€67,980
▼ 7.7%
€208,316
▼ 11.4%
28.3%
▼ 37.2 percentage points
2.09
▼ 1.25

Turnover is estimated at about €900,000, probably between €590,000 and €1.9m. The abbreviated or micro format does not state turnover.

Balance sheet

balance sheet total €1.3m on 31-03-2026
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

28.3%

Higher than 40% of the 13,315 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

2.09

Higher than 65% of the 13,174 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

5.4%

Higher than 55% of the 13,235 companies filing abbreviated accounts in retail trade (NACE 47) in 2025.

HM Pharma Middle half of the sector 80% of the sector Abbreviated accounts in retail trade (NACE 47)

Staff

€41,592

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20262025202420232022
109,093120,312110,204103,92993,946
86,51291,76589,70183,48278,322
772,07803,51749,507106,849
42,93734,67284,107-69,093-
208,316235,156154,25977,196157,449
28.3%65.5%51.9%43.1%19.8%
2.093.352.141.672.60
1.412.111.320.761.51
2.540.530.931.324.06
19.2%25.7%33.8%50.4%98.6%
5.4%16.8%17.5%21.7%19.5%
34.0427.0222.5831.4622.45

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20262025202420232022
Balance sheet: assets
20/58 1.3m437,528409,860327,404353,326
21/28 855,722102,176120,253134,55997,398
22/27 98,962100,553118,629132,93697,398
22 63,53667,16378,06988,97696,697
23 2,6082,5043,4721,555-
24 32,81830,88637,08742,405701
28 756,7601,6241,6241,624-
29/58 398,750335,351289,607192,845255,928
3 129,479123,732110,437104,460107,336
30/36 129,479123,732110,437104,460107,336
40/41 17,69013,87510,59610,91212,518
40 3,3606,7877,3846,58712,518
41 14,3307,0883,2124,325-
54/58 181,683138,746104,07319,96789,059
490/1 69,89958,99864,50157,50747,015
Balance sheet: equity and liabilities
10/49 1.3m437,528409,860327,404353,326
10/15 354,554286,574212,885141,00869,871
10/11 1,0001,0001,0001,0001,000
13 353,554285,574211,885140,00868,871
133 353,554285,574211,885140,00868,871
17/49 899,919150,953196,975186,397283,455
17 704,06539,91959,35266,974182,875
170/4 704,06539,91959,35266,974182,875
42/48 190,434100,195135,348115,64998,479
42 70,8547,4337,62210,61110,490
44 101,49566,90791,81371,53757,923
440/4 101,49566,90791,81371,53757,923
45 18,08525,85535,91333,50129,006
450/3 1,72010,81821,34719,84914,628
454/9 16,36515,03714,56613,65214,378
47/48 ----1,061
492/3 5,42010,8392,2743,7742,100
Income statement
9900 192,466196,403184,268171,578165,801
62 83,18575,90573,89067,48771,801
630 18,53218,07617,82412,3469,451
640/8 18818617516255
9901 90,561102,23692,38091,58384,495
75/76B 5,0132,8434,2081,919994
75 5,0132,8434,2081,919994
65/66B 3,2054,4524,8823,3034,184
65 3,2054,4524,8823,3034,184
9903 92,368100,62791,70690,19981,304
67/77 24,38926,93819,82919,06312,433
9904 67,98073,68971,87871,13668,871
9905 67,98073,68971,87871,13668,871
Appropriation of the result
9906 67,98073,68971,87871,13668,871
691/2 67,98073,68971,87871,13668,871
6921 67,98073,68971,87871,13668,871
Social balance sheet
9087 2222.52
Hours worked1013 1,9722,0311,9831,6581,878
Document PDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2026 at the NBB, filed on 28-09-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-03-2026 abbreviated format 28-09-2026 2026-00532152 PDF
31-03-2025 abbreviated format 14-10-2025 2025-00543394 PDF
31-03-2024 abbreviated format 15-10-2024 2024-00508333 PDF
31-03-2023 abbreviated format 09-10-2023 2023-00480810 PDF
31-03-2022 micro format 10-10-2022 2022-20458272 PDF

Subsidies and aid

Flemish government 2023, 1 entry, €159 awarded, €159 paid

Social balance sheet

Item31-03-202631-03-202531-03-202431-03-202331-03-2022
Employees at the balance-sheet date22222
part-time22222
in full-time equivalents1.11.11.11.11.1
1.11.11.11.21.1
On a permanent contract22222
Joined---12
Left---10

Source: social balance sheet in the 2022 to 2026 annual accounts

Investments

fixed assets acquired
Item31-03-202631-03-202531-03-202431-03-202331-03-2022
Tangible fixed assets€16,942-€3,517€47,884€106,849
Financial fixed assets€755,136--€1,624-
€18,532€18,076€17,824€12,346€9,451

Source: notes to the 2022 to 2026 annual accounts (statement of fixed assets)

Insights on HM Pharma

The operating result for 2026 is 11% lower than in 2025 and the lowest since 2022.

Debt's share of the balance-sheet total rises from 34.5% to 71.7%. Equity and debt are higher.

Next steps